Amir Lerman, MD
Cardiovascular Disease · Rochester, MNNPI 1649257171
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $436,794 of the $465,103 with a category attached, or 93.9%. Itamar Medical Inc accounts for 77.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $301,052 and has fallen 99.9% since, to $194 in 2025. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $6371.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Itamar Medical Inc$361K
- Philips North America LLC$37K
- Corindus Inc.$19K
- Astrazeneca AB$17K
- Abbott$9K
- Genetesis, Inc.$8K
- plus $15K from 5 others
Across 23 payments — averaging $22,906 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$277K
- Philips North America LLC$230K
- Neovasc Medical Inc$19K
What the payments were for
- Consulting fees$436,79494%
- Speaking & faculty fees$4,4951%
- Travel & lodging$21,7385%
- Food & beverage$2,0760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Itamar Medical Inc | 5 | $360,683 |
| Philips North America LLC | 42 | $37,034 |
| Corindus Inc. | 2 | $18,750 |
| Astrazeneca AB | 8 | $16,647 |
| Abbott | 8 | $8,691 |
| Genetesis, Inc. | 1 | $8,310 |
| Biobeat USA Inc. | 1 | $8,000 |
| Regeneron | 2 | $3,604 |
| Sanofi-aventis U.S. LLC | 1 | $2,995 |
| Neovasc Medical Inc | 2 | $285 |
| Shockwave Medical, Inc | 1 | $103 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WatchPat$360,683
- (9520) IGT Devices Undivided$30,541
- CardioFlux$8,310
- BB-613 BPM kit$8,000
- Dragonfly OCT$5,750
- Spectranetics Undiv$5,362
- SAR247799$2,995
- (6574) Coronary Other$253
- IGT Systems Und$228
- IGT D Serv Und$207
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$103
How this compares
$465,103 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $279 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Rochester
- Srijoy MahapatraRochester$1.2M
- Charanjit RihalRochester$478K
- Martha GroganRochester$330K
- Virend SomersRochester$262K
- Francisco Lopez-JimenezRochester$167K
- Ammar KilluRochester$139K
- Allan JaffeRochester$111K
- Robert McBaneRochester$110K
- Michael McGoonRochester$106K
- R Scott WrightRochester$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.